A 40‐week phase 2B randomized, multicenter, double‐blind, placebo‐controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis von Bhai, Salman, Levine, Todd, Moore, Dan, Bowser, Robert, Heim, Andrew J., Walsh, Maureen, Shibani, Aziz, Simmons, Zachary, Grogan, James, Goyal, Namita A., Govindarajan, Raghav, Hussain, Yessar, Papsdorf, Tania, Schwasinger‐Schmidt, Tiffany, Olney, Nick, Goslin, Kim, Pulley, Michael, Kasarskis, Edward, Weiss, Michael, Katz, Susan W., Moser, Suzan, Jabari, Duaa, Jawdat, Omar, Statland, Jeffrey, Dimachkie, Mazen M., Barohn, Richard

Volltext

Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil: A Randomized Controlled Trial von Tariot, Pierre N, Farlow, Martin R, Grossberg, George T, Graham, Stephen M, McDonald, Scott, Gergel, Ivan, for the Memantine Study Group

Volltext

Memantine in Moderate-to-Severe Alzheimer's Disease von Reisberg, Barry, Doody, Rachelle, Stöffler, Albrecht, Schmitt, Frederick, Ferris, Steven, Möbius, Hans Jörg

Volltext

Memantine effects on behaviour in moderately severe to severe Alzheimer’s disease: a post-marketing surveillance study von Clerici, Francesca, Vanacore, Nicola, Elia, Antonietta, Spila-Alegiani, Stefania, Pomati, Simone, Da Cas, Roberto, Raschetti, Roberto, Mariani, Claudio

Volltext

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment von CUMMINGS, Jeffrey L, SCHNEIDER, Eugene, TARIOT, Pierre N, GRAHAM, Stephen M

Volltext

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease von VAN DVCK, Christopher H, TARIOT, Pierre N, MEVERS, Barnett, MALCA RESNICK, E

Volltext

A Responder Analysis of Memantine Treatment in Patients With Alzheimer Disease Maintained on Donepezil von van Dyck, Christopher H., Schmitt, Frederick A., Olin, Jason T.

Volltext

Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer's disease von OTT, Brian R, BLAKE, Lesley M, KAGAN, Ethel, RESNICK, Malca

Volltext

Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial von Peskind, Elaine R., Potkin, Steven G., Pomara, Nunzio, Ott, Brian R., Graham, Stephen M., Olin, Jason T., McDonald, Scott

Volltext

Cognitive response to memantine in moderate to severe alzheimer disease patients already receiving donepezil : An exploratory reanalysis von SCHMITT, Frederick A, VAN DYCK, Christopher H, WICHEMS, Christine H, OLIN, Jason T

Volltext

Activities of daily living in moderate-to-severe alzheimer disease : An analysis of the treatment effects of memantine in patients receiving stable donepezil treatment von FELDMAN, Howard H, SCHMITT, Frederick A, OLIN, Jason T

Volltext

Memantine in Moderately-Severe-to-Severe Alzheimer’s Disease: A Postmarketing Surveillance Study von Clerici, Francesca, Vanacore, Nicola, Elia, Antonietta, Spila-Alegiani, Stefania, Pomati, Simone, Da Cas, Roberto, Raschetti, Roberto, Mariani, Claudio

Volltext